Gritstone bio, Inc. (GRTS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	8-K	10-K	8-K	10-K	10-K	10-K	10-K
Total revenues	19.9	19.9	48.2	48.2	4.0	4.4	1.2
Total revenues growth	-58.6%	-58.6%	1094.3%		-7.5%	267.7%
Operating expenses:
Research and development							55.0	35.7
General and administrative		29.0		25.9			11.8	6.1
Total operating expenses	140.4	140.4	123.4	123.4	110.1	102.3	66.8	41.8
Loss from operations	-120.4	-120.4	-75.2	-75.2	-106.0	-97.9	-65.6	-41.8
Operating margin	-603.8%	-603.8%	-156.0%	-156.0%	-2626.1%	-2243.8%	-5525.2%
Interest income		0.7		0.1			0.8	0.4
Interest Expense		-1.2		0.0
Net loss		-119.7		-75.1			-64.8	-41.4

Other comprehensive loss:
Comprehensive loss		-119.7		-75.2			-64.8	-41.4

Net loss per share, basic	($1.32)	($1.32)	($0.95)	($0.95)	($2.79)	($2.81)	($7.26)	($20.70)
Net loss per share, diluted	($1.32)	($1.32)	($0.95)	($0.95)	($2.79)	($2.81)	($64,775,000.00)	($20.70)

Weighted-average number of shares used in computing net loss per share, basic	90.9	90.9	78.9	78.9	37.8	33.6	8.9	2.0
Weighted-average number of shares used in computing net loss per share, basic, diluted	90.9	90.9	78.9	78.9	37.8	33.6